Open Access

Halomonas sp. BS4, A biosurfactant producing halophilic bacterium isolated from solar salt works in India and their biomedical importance

  • Mariathason Birdilla Selva Donio1,
  • Fernando Arul Ronica1,
  • Vijayaragavan Thanga Viji1,
  • Subramanian Velmurugan1,
  • John Selesteen Charles Adlin Jenifer1,
  • Mariavincent Michaelbabu1,
  • Prasenjit Dhar2 and
  • Thavasimuthu Citarasu1Email author
SpringerPlus20132:149

https://doi.org/10.1186/2193-1801-2-149

Received: 23 January 2013

Accepted: 25 March 2013

Published: 10 April 2013

Abstract

Halophilic bacteria were isolated from Thamaraikulam solar salt works in India. After routine biosurfactant screening by various methods, the biosurfactant producing bacteria, Halomonas sp BS4 was confirmed by 16 S rRNA sequencing. The growth optimization of Halomonas sp BS4 revealed their optimum growth at 8% NaCl and 6-8 pH in the growth medium. Further the partially purified biosurfactants were characterized by TLC, FTIR and GC-MS analysis. GC-MS results revealed that, the partial purified biosurfactants contain 1, 2-Ethanediamine N, N, N’, N’-tetra, 8-Methyl-6-nonenamide, (Z)-9-octadecenamide and a fatty acid derivative. Pharmacological screening of antibacterial, antifungal, antiviral and anticancer assays revealed that, the biosurfactant extracted from Halomonas sp BS4 effectively controlled the human pathogenic bacteria and fungi an aquaculturally important virus, WSSV. The biosurfactant also suppressed the proliferation of mammary epithelial carcinoma cell by 46.77% at 2.5 μg concentration. Based on these findings, the present study concluded that, there is a possibility to develop eco-friendly antimicrobial and anticancer drugs from the extremophilic origin.

Keywords

Biosurfactants Halomonas White spot syndrome virus (WSSV) Antimicrobial activity

Introduction

Molecular activities individually and in mixtures are initials and signatures for originating scientific simulations and frameworks for academic as well as new industrial upcoming. It is more important with biomolecules such as egg-phosphatidylcholine (EPC) which being weakly polar are involved in molecular interactions as emulsifying agent (Ponder and Case, 2003; Warshel et al. 2006). Surfactants and emulsifiers are indispensable components of daily life (Siegmund, 2002). Microbial compounds that exhibit pronounced surface and emulsifying activities are classified as biosurfactants. Biosurfactants are biological surface-active compounds released by microorganisms that can have some influence on interfaces (Yeh et al. 2006; Joshi et al. 2008). Biosurfactants are amphiphilic compounds produced on living surfaces, mostly microbial cell surfaces or excreted extracellularly and contain hydrophobic and hydrophilic moieties. They reduce surface tension and interfacial tension between individual molecules at the surface and interface respectively (Karanth et al. 1999).

Recently, an increase in the concern about environmental protection has caused the development of cost-effective bioprocesses for biosurfactant production (Morita et al. 2007). The microbial surfactants (MS) are complex molecules covering a wide range of chemical types including peptides, fatty acids, phospholipids, glycolipids, antibiotics, lipopeptides, etc. Research in the area of biosurfactants has expanded quite a lot in recent years due to its potential use in different areas. Most of the biosurfactants used as antibacterial, antifungal or antiviral agents are required in very low concentrations as expressed by their MIC (minimum inhibitory concentration) index. This factor makes biosurfactants highly sought after biomolecules for present and future applications as fine specialty chemicals, biological control agents, and new generation molecules for pharmaceutical, cosmetic and health care industries. Biosurfactants are not only useful as antibacterial, antifungal and antiviral agents; they also have potential for use as major immunomodulatory molecules, adhesive agents and even have use in vaccines and gene therapy. Biosurfactants have several advantages compared with synthetic surfactants: lower toxicity, higher biodegradability, better environmental compatibility, higher foaming, higher selectively and specific activity at extreme temperatures, pH and salinity, and the ability to be synthesized from renewable feedstock (Kumar et al. 2006).

The involvement of biosurfactants in microbial adhesion and detachment from surfaces has been previously investigated. A surfactant released by Streptococcus thermophilus has been used for fouling control of heat-exchanger plates in pasteurizers as it retards the colonization of other thermophilic strains of Streptococcus responsible for fouling (Busscher et al. 1996). Possible applications of biosurfactants as emulsifying agents for drug transport to the infection site, as agents supplementing the pulmonary surfactant and as adjuvants for vaccines were suggested by Kosaric (Kosaric, 1996). In the present study, we have studied the production, optimization, characterization and biomedical application of biosurfactants obtained from halobacterium, Halomonas sp BS4 isolated from solar salt works.

Materials and methods

Isolation and characterization of Halomonas sp BS4

Condenser water having a salinity of 155% was collected from the solar salt works in Thamaraikulam, Kanyakumari district, Tamilnadu, India (Lat. 8° 11’ N and Long.77° 29’ E). Samples were collected in sterile polythene bags, trans-ported to the laboratory aseptically and stored at 4°C for further use. Water samples were serially diluted from 10-1 to 10-8 in sterile salt pan water and 100 μl of each dilution was spread onto sterile nutrient agar plates containing 5 to 20% NaCl. The plates were incubated at 37°C for 7 days. After incubation morphologically different colonies were identified by morphology and biochemical confirmations as well as based on the characteristics described in Bergey’s Manual of Systematic Bacteriology (Holt et al. 1994).

Genomic DNA (100 ng) isolated from halophilic Halomonas sp BS4 strain was amplified by PCR using 16 S rRNA universal primers (Forward: 5 CAGGCCTAACACATGCAAGTC 3; Reverse: 5 GGGCGGWGTGTACAAGGC 3). The PCR product was cloned into the vector pTZ57R and used to transform Escherichia coli DH5α as described by Sambrook et al.1989). The transformants were sequenced using an ABI 3700 automated DNA sequencer. Sequences were compared with other 16 S rRNAs obtained from GenBank using the BLAST program. The phylogenetic tree was constructed by MEGA5 software and evolutionary history was inferred using the UPGMA method (Sneath and Sokal, 1973). The evolutionary distances were computed using the Maximum Composite Likelihood method (Tamura et al. 2004) and are in the units of the number of base substitutions per site. The optimal tree with the sum of branch length = 0.31662628 is shown.

Growth optimization of Halomonas sp BS4

Bacterial isolates were evaluated at various pH (5-10) and sodium chloride concentrations (2-20%) in nutrient broth to find out the optimum growth conditions. The optical density at 600 nm wavelength was measured for evaluating bacterial growth in broth culture.

Biosurfactant screening, extraction and purification

Different biosurfactant screening methods were done for finding out potential biosurfactant producing halophilic Halomonas sp BS4. The methods adopted were (a) drop-collapse test by adding mineral oil in 96-well microtitre plates (Jain et al. 1991); (b) Oil spreading technique by adding weathered crude oil (Youssef et al. 2004); (c) Emulsification activity by adding kerosene and equal volume of cell free supernatant (Cooper and Goldenberg, 1987) and (d) Hemolytic activity in 5% blood agar plate.

The biosurfactant was extracted from cell-free broth at 72-h grown cells by step-by-step purification of acid precipitates using adsorption chromatography. Bacterial cells were removed from surfactant-containing medium by centrifugation (10,000 rpm for 20 min). The supernatant was subjected to acid precipitation by adding 6 N HCl to achieve a final pH of 2.0 and allowing precipitating at 4°C. The precipitate was pelleted at 10,000 rpm for 20 min, re-dissolved in distilled water, adjusted to pH 7.0, freeze-dried, and weighed. The dried surfactant was extracted with acetone and dried with the aid of a rotary evaporator under vacuum (Pruthi and Cameotra, 1997).

Structural characterization of biosurfactants

The dried biosurfactants obtained from acid precipitation method was dissolved with distilled water and spotted on TLC (Merck) sheets and run with CHCl3/CH3OH/H2O (65:15:1) as mobile phase. The chromatogram was developed under short UV light as well as exposing iodine vapour. The Rf value was calculated as per the standard database of biosurfactants (Janek et al. 2010).

The basic functional groups of the purified biosurfactants from halophilic Halomonas sp BS4 were analyzed qualitatively by Fourier Transform Infra Red (FTIR) method described by Kemp (1991).

GC-MS analysis of partially purified biosurfactants were analysed individually using Agilent GC-MS 5975 Inert XL MSD (United States) gas chromatography equipped with J and W 122 – 5532G DB-5 ms 30 × 0.25 mm × 0.25 μm and mass detector (EM with replaceable horn) was operated in EMV mode. Helium was used as carrier gas with the flow rate of 1.0 ml min-1. The injection port temperature was operated at 250°C. The column oven temperature was held at 80°C for 2 min then programmed at 10°C min-1 to 250°C, which was held for 0 min, and then at 5°C min-1 to 280°C which was held for 9 min. Electron impact spectra in positive ionization mode were acquired between m/z 40 and 450.

Pharmacological screening of biosurfactants

In vitro antibacterial activity was performed by the partial purified biosurfactants against few human pathogens (Staphylococcus aureus, Klebsiella pneumonia, Streptococcus pyrogenes and Salmonella typhi) using agar diffusion method and agar over layer method. The pathogens was inoculated at the rate of 1 × 10-4 cfu/ml. For anti fungal activity, 20 μl of biosurfactant was poured into a well made in the centre of Potato Dextrose Agar (PDA) plates and fungal spores (approximately 10 spores) were inoculated onto the plates and incubated at 35°C for 48 hr. The zone of inhibition was recorded.

Antiviral activity was performed against White Spot Syndrome Virus (WSSV) following the method of Balasubramanian et al. (2006). Five micro litre of purified WSSV suspension (300 μg of total protein) was mixed with different concentraions of biosurfactants (2, 4, 6, 8 and 10 μg/μl) and incubated at 29°C for 3 h. After incubation period, the mixture was injected intramuscularly to Fenneropenaeus indicus had the average weight of 10 ± 1 g. Three replicates were (n= 10 × 3= 30) maintained in all treatments. Mortalities were recorded daily and the experiment was carried out up to 10 days. Control shrimps were injected with a mixture of 10 μl NTE buffer and 5 μl viral suspensions. Haemolymph samples were collected from all injected shrimps and checked by WSSV diagnostic PCR using VP28 primer designed by Namita et al. (2007). The DNA extraction and PCR amplification were carried out by following the method described by Chang et al. (1999). Haemolymph samples of experimental and control shrimps were tested by the first step PCR. The negative samples detected in the first step were further subjected for second step PCR analysis. For this experiment, ethical clearance was obtained from Manonmaniam Sundaranar University ethical committee, Tirunelveli, India (Ref. : MSU/Ethical /2011/4 dtd 28.8.2011).

The anticancer activity was performed in tumor mammary epithelial carcinoma cell lines with the partial purified biosurfactants extracted from halophilic Halomonas sp BS4 following the method of Freshney (2007) and the activity was monitored after 48 hrs.

Results

Three different colonies were isolated from agar plates based on the colour such as pink, creamy and creamy white. The isolates were moderately halophilic (5-15%) and rod shaped. As per the biochemical results, the selected strains may be Halomonas sp BS4, Bacillus sp and Bacillus subtilis (Table 1). The selected bacterial strain (Halomonas sp BS4) was identified taxonomically using 16 S rRNA gene sequence. To determine their phylogenetic position, the 16 S rRNA gene sequence was analysed and phylogenetic tree was constructed. Phylogenetic analysis also indicated that the selected isolate BS4 belonged to the genera Halomonas (Figure 1).
Table 1

Phenotypic identification of biosurfactant producing Halomonas sp BS4 isolated from solar salt works in India in comparison with other Halomonas sp

Characteristics

Halomonas sp-BS4

H. salina#

H. halophila#

H. elongate#

H. eurihalina#

Colony Colour

Pink

Cream-yellow

Cream

Cream-beige

Cream

Cell morphology

Short rod

Short rod

Rod

Long Rod

Short Rod

Motility

+

ND

ND

ND

ND

Indole

-

ND

ND

ND

ND

Methyl Red

-

ND

ND

ND

ND

VP

-

ND

ND

ND

ND

NaCl range (% W/v)

0-20

2–20

2–30

0–25

3.5–25

NaCl optimum (% W/v)

8.0

5.0

7.5

11.0

2.0

pH range

5.0-10.0

5.0–10.0

5.0–10.0

5.0–9.0

5.0–10.0

Temperature range

15-45

4–45

10–45

15–45

4–45

Nitrate reduction

+

+

+

+

+

Oxidase

-

+

+

-

-

Hydrolysis:

     

1. Gelatin

+

-

-

+

+

2. Urea

+

+

+

+

+

3. Tyrosine

+

+

-

-

+

EPS production

+

+

-

-

+

Acid from:

     

1. D-Glucose

+

-

+

+

-

2. L- Arabinose

-

-

+

-

+

3. D-Galactose

-

-

+

-

-

4. Lactose

-

-

-

+

-

5. Maltose

+

-

+

+

-

6. Mannose

-

-

+

-

-

7. Sucrose

+

-

-

+

-

8. Trehalose

ND

-

+

+

-

GC Content (%)

53

60.5

59.1

60.4

66.7

#: The data obtained from Romano et al. (1997); ND: Not Determined.

Figure 1

Graphical phylogenetic tree analysis of Halomonas sp. BS4 based on 16S rRNA gene sequence data compare with other sp.

The growth condition of the selected strain (Halomonas sp BS4) was optimized by NaCl concentration and pH (Figure 2a and 2b). The purpose of optimization of the strains was to find their optimum growth. From the results it was concluded that the Halomonas sp BS4 grow highest on 8% NaCl. Similarly, pH was checked for the selected strain that grows best in the range of 6-8 pH.
Figure 2

Growth optimization of Halomonas sp BS4 isolated from solar salt works grown in NaCl concentrations (a) and pH (b). The values are significantly differed each other’s (F = 78.88; P < = 0.001- Figure 2a) and (F = 48.36; P < = 0.001- Figure 2b) – Two Way ANOVA.

Among the different biosurfactant screening tests such as drop collapse test, Oil spreading technique, Emulsification activity and Hemolytic activity, biosurfactant producing ability was found only in the selected strain Halomonas sp BS4 where as compared to the selected strain (Halomonas sp BS4) very low or negative result was observed from the other isolates (Bacillus sp and Bacillus subtilis) (Table 2).
Table 2

Biosurfactant screening Halomonas sp BS4 isolated from solar salt works in India

Bacterial strains

Drop collapse test

Oil spreading test

Emulsification activity

Haemolytic activity

Halomonas sp BS4*

+++

+++

+++

++++

Bacillus sp**

-

-

-

-

Bacillus subtilis***

++

+

+

+

* Halomonas sp BS4 isolated from solar salt works; ** Bacillus sp isolated from solar salt works and *** Bacillus subtilis isolated from back water of Rajakkamangalam, India.

TLC analysis showed that the production of biosurfactant by Halomonas sp BS4 cultivated in mineral salt medium detected spots with Rf value of 0.40. The IR spectrum in KBr showed bands characteristic of peptides at 3431 cm-1 (NH stretching mode). The band at 2362 cm-1 is due to the presence cumulated system R2C = N = N in the sample. The absorption at 1639 cm-1 is possible due to either stretching of –C = C, stretching of carboxylate anion. The peak at 576 cm-1 and the peaks at 443 and 410 cm-1 confirm the presence of C-Br and C-I bond in the sample (Figure 3).
Figure 3

Functional group analysis of Halomonas sp BS4 yield biosurfactants by Fourier Transmission Infra Red (FTIR) spectroscopic analysis.

The fraction chosen for GC-MS gave peaks corresponding to long chain aliphatic compounds consistent with fatty acid methyl esters. It is highly unlikely that such compounds would exhibit a bioactive response when subjected to the tests performed in this study, indicating that the bioactive compound is located in one of the other fractions. The analyzed fraction was reasonably pure, with 3 main constituents, including 1, 2-Ethanediamine N, N, N’, N’-tetra,8-Methyl-6-nonenamide, (Z)-9-octadecenamide, the amide of oleic acid, which is a fatty acid derivative (Table 3).
Table 3

Major compounds identified from the partial purified biosurfactants from Halomonas sp BS4 by GCMS analysis

Sl. no

Retention time

Name of the compounds

Molecular formula

Molecular weight

Quality %

1.

2.133

1, 2-Ethanediamine, N, N, N’, N’-tetra

C6H16N2

116.2046

86

2.

30.333

8-Methyl-6-nonenamide

C10H19NO

169.2640

53

3.

30.411

9-Octadecenamide, (Z)

C18H35NO

281.4766

53

The Halomonas sp BS4’s biosurfactants effectively inhibited the growth of pathogenic bacteria as well as fungi (Table 4). The antibacterial activity against Staphylococcus aureus, Klebsiella pneumonia, Streptococcus pyrogenes and Salmonella typhi was detected by observing a zone of inhibition of 15.35, 15.60, 11.98 and 17.33 mm respectively. A higher antifungal activity was observed against Aspergillus niger and Fusarium sp. while moderate activity was noticed against Aspergillus flavus and Trichophyton rubrum. The antiviral effect of the biosurfactant against White Spot Syndrome Virus (WSSV) revealed that, higher percentages (60, 80 and 100%) of biosurfactant effectively suppressed the growth/pathological effect of WSSV. All the WSSV injected shrimp in the positive control group succumbed to death within 5 days of post inoculation whereas the surfactant treated groups had prolonged survival rates and exhibited very less mortality of 70 and 90% at the end of experiment. One step PCR detection also supported the higher percentages of biosurfactants. There is no positive PCR signals observed in 80 and 100% of biosurfactants due to cent percent suppression of virus growth (Figure 4). Various concentrations of biosurfactants treated mammary epithelial carcinoma cell were given in the Figure 5. The concentrations of 0.00025 μg suppressed the cells of 4.44%; 0.0025 supressed 12.67%; 0.025 suppressed 28.95%, 0.25 suppressed 40.32% 2.5 suppressed 46.77% and 25 μg suppressed the maximum of 47.42%.
Figure 4

PCR detection of haemolymph samples ofPenaeus monodonafter injection with various percentages of biosurfactant incubated with WSSV. Statistical differences (P < 0.01) between treated and control groups are indicated by a-f superscripts; error bars are standard errors- One way ANOVA.

Table 4

In vitro antibacterial and antifungal activity of partial purified biosurfactants from Halomonas sp BS4

Sl. no

Antibacterial activity

Antifungal activity

 

Bacterial pathogens

Activity (mm of zone of inhibition)

Fungal pathogens

Activity

1

Staphylococcus aureus

15.35 ± 0.78a

Trichophyton rubrum

+++

2

Klebsiella pneumonia

15. 60 ± 0.85 a

Aspergillus niger

++++

3

Streptococcus pyrogens

11.98 ± 0.45 b

Aspergillus flavus

+++

4

Salmonella typhi

17.33 ± 0.15 c

Fusarium sp

++++

++++: higher activity; ++: medium activity; +: less activity.

Means with the same superscripts (a-c) do not differ from each other (P < 0.001)- One way ANOVA.

Figure 5

Anti tumor activity performed in tumor mammary epithelial carcinoma cell lines with various percentages of Halomonas BS4 yield biosurfactants. Statistical differences (P < 0.001) between treated and control groups are indicated by a-f superscripts and asterisks indicates non significant; error bars are standard errors- One way ANOVA.

Discussion

Biosurfactants are produced by several types of microorganisms, such as bacteria, fungi and yeasts (Fiechter 1992). Some microorganisms are capable of growing in extreme environments, where most other organisms are not able to survive. Among these extremophiles, halophiles are one of the major microbial communities that tolerates high salt concentrations and are highly sought after by many industries for their novel enzymes and products that has wider potential applications (Ventosa et al. 1998). Halomonas is a Gram-negative bacterium, non-spore forming, predominantly present in marine environments and are often isolated from deep-sea sediments and hydrothermal vents. Halomonas sp. comprises a remarkably high percentage (up to N10%) of the total microbial community in their habitat (Kaye and Baross 2000). Most of the Halomonas sp. that has been reported for EPS production has been isolated from hypersaline environments with different salt concentration (Martínez-Checa et al. 2002; Quesada et al. 2004a). Gutierrez et al. (2009) isolated and studied physicochemical properties of EPS namely HMWEPS from Halomonas sp. strain TG39 by growing on different types of substrates.

There are very few reports on biosurfactant producers in hypersaline environments (Cameotra and Makkar 1998). Halophiles, which have a unique lipid composition (phytanylglycerol), may have an important role to play as surface-active agents. The archae bacterial ether-linked phytanyl membrane lipid of the extremely halophilic bacteria has been shown to have surfactant properties (Post and Collins 1982). According to Tsuge et al. (1996), lipopeptide surfactants are potent antibiotics mainly the surfactin, streptofactin and gramicidin produced by the microorganism had the wide antimicrobial activity (Peypoux et al. 1999). This is consistent with the fact that 50% of secondary metabolites are terpenes, 25% are acteogenins (polyketides) and 25% are fatty acid derived (Blackman 2005). As previously described for rhamnolipid molecules containing two different 3-hydroxy fatty acid side chains, rhamnolipid molecules with the shorter 3-hydroxy fatty acid side chain are found to be more abundant than those with the longer chain connected to the rhamnose molecule at the same position (De’ziel 2000).

The present study TLC analysis revealed that, the Rf value of 0.40 confirmed as Glycolipid. George and Jayachandran (2009), studied the production of biosurfactant from P. aeruginosa MTCC2297 cultivated in orange fruit peelings detected spots with Rf values of 0.19 (dirhamnolipids), 0.36 (monorhamnolipids), 0.59 and 0.71 (various rhamnolipid forms), 0.82 and 0.98 in silica plates. Haba et al. (2000), on the other hand, observed that Pseudomonas sp. cultivated in medium supplemented with used vegetable oils produced a mixture of two rhamnolipids with Rf value of 0.7 and 0.45. Arino et al. (1996) characterized the rhamnolipid mixture produced by P. aeruginosa GL1. The Rf values for different spots were calculated and it corresponds to R1 0.72 (Rha-C10C10,), R2 0.40 (Rha-C10), R3 0.32 (Rha-Rha-C10C10) and R4 0.13 (Rha-Rha- C10). The Glycolipid biosurfactant was characterized from Halomonas sp by FTIR and TLC analysis. The GC –MS analysis revealed that, the biosurfactant of halophilic Halomonas sp BS4 contain polymers, fatty acids and other compounds including 1, 2-Ethanediamine N, N, N’, N’-tetra, 8-Methyl-6-nonenamide, (Z)-9-octadecenamide etc. In the present study, the biosurfactant contain, 1, 2-Ethanediamine N, N, N’, N’-tetra, at the quality of 86% and 9-Octadecenamide, (Z) at 53% quality. The sponge associated actinomycetes, Nocardiopsis dassonvillei MAD08 contains 9-octadecenamide (Z) that had the broad range of antimicrobial activity including anticandid activity (Selvin et al. 2009). 1,2-Ethanediamine, N,N,N’,N’-tetramethyl- is a polymeric biosurfactant also present in the biosurfactant of the Halomonas sp BS4 at high quality level. 1,2-Ethanediamine, N,N,N’,N’-tetramethyl- had a broad pharmacological activities including anti tumor and antifungal activities. Its anti fouling activity in aqueous system is also shown to be microbicidal and thus preventing adhesion of bacteria. This polymeric biosurfactant also suppressed the motility, temporary attachment of hydroid larvae Dynarnena pumila and Obelia loveni and prevent the attachment and contractility of young blue mussels Mytilus edulis (Railkin1994). Halomonas species produce emulsifiers which is effective in a wide range of food oils under both neutral and acidic pH conditions, even under high temperature and acidic conditions (Gutierrez 2009).

The ability of a mixture of seven different rhamnolipids to inhibit microbial growth was determined by Abalos et al. (2001). Low concentrations were able to inhibit the bacteria Staphylococcus epidermidis, E. coli and Alcaligenes faecalis. Also inhibited the growth of fungi Aspergillus niger, Glicadiam virans, Boryttis cinera and Penicillium crysogenum. The present results revealed that the biosurfactants extracted from Halomonas sp BS4 were able to suppress the bacteria Staphylococcus aureus, Klebsiella pneumonia, Streptococcus pyrogenes and Salmonella typhi at more than 10 mm of zone of inhibition. Isoda et al. (1999) investigated the antibacterial activities of seven extracellular microbial glycolipids, including MEL-A, MEL-B, polyol lipid, rhamnolipid, SL and succinoyltrehalose lipids STL-1 and STL-3. The biosurfactant also effectively suppress the growth of the fungi such as Aspergillus niger, Trichophyton rubrum, Fusarium sp and Aspergillus flavus. Nielsen et al. (1999) reported viscosinamide, a cyclic depsipeptide, to be a new antifungal surface-active agent produced by Pseudomonas fluorescens, with different properties compared with the biosurfactant viscosin.

Glycolipids have also been implicated in growth arrest, apoptosis and the differentiation of mouse malignant melanoma cells (Zhao 2000). The biosurfactant also have some anticancer activities, they suppress the cell viability in tumor mammary epithelial carcinoma cells at 25% in the 25 μg concentrations. Arena et al. (2009 Vollenbroich et al.) reported novel type of EPS-1 polysaccharide had an antiviral and immunomodulatory effect which was produced by thermo tolerant strain Bacillus licheniformis. (1997) showed that surfactin is active against several viruses, including Semliki Forest virus, herpes simplex virus (HSV), Suid herpes virus, vesicular stomatitis virus, simian immunodeficiency virus, feline calicivirus and murine encephalomyocarditis virus. In the present study, the biosurfactant incubated WSSV injected shrimps had improved survival when compared with the control. The 100% biosurfactant treated group had increased survival to 3 times. The present findings revealed that the biosurfactant isolated from the Halomonas sp BS4 had wider pharmacological activities and this will help to develop novel drugs. Further studies are needed to improve the biosurfactant production and purification of the various compounds such as glycolipids, polymeric substances and lipopeptides from the Halomonas sp BS4.

Declarations

Acknowledgements

One of the authors Miss. F. A. Ronica gratefully acknowledges the Tamil Nadu State Council for Science and Technology (TNSCST), Chennai, for its financial support in the form of student project scheme 2010-11(Ms-004/ TNSCST/SPS/AR/2010-2011).

Authors’ Affiliations

(1)
Centre for Marine Science and Technology, Manonmaniam Sundaranar University
(2)
Department of Veterinary Microbiology, COVAS, CSKHPKV

References

  1. Abalos A, Pinazo A, Infante MR, Casals M, Garcia F, Manresa A: Physicochemical and antimicrobial properties of new rhamnolipids produced by Pseudomonas aeruginosa at10 from soybean oil refinery wastes. Langmuir 2001, 17: 1367-1371. 10.1021/la0011735View ArticleGoogle Scholar
  2. Arena A, Gugliandolo C, Stassi G, Pavone B, Iannello D, Bisignano G, Maugeri TL: “An exopolysaccharide produced by geobacillus thermodenitrificans strain B3–72: antiviral activity on immunocompetent cells”. Immunol Lett 2009, 123(2):132-137. 10.1016/j.imlet.2009.03.001View ArticleGoogle Scholar
  3. Arino S, Marchal R, Vandecasteele JP: Identification and production of a rhamnolipidic biosurfactant by a Pseudomonas species. Appl Environ Microbiol 1996, 45: 162-168.Google Scholar
  4. Balasubramanian G, Sarathi M, Rajesh Kumar S, SahulHameed AS: Screening the antiviral activity of Indian medicinal plants against white spot syndrome virus in shrimp. Aquaculture 2006, 263: 15-19.View ArticleGoogle Scholar
  5. Blackman AJ: Biosynthesis and function of natural products laboratory manual. Hobart: University of Tasmania; 2005.Google Scholar
  6. Busscher HJ, van der Kuij-Booij M, van der Mei HC: Biosurfactants from thermophilic dairy streptococci and their potential role in the fouling control of heat exchanger plates. J Ind Microbiol Biotechnol 1996, 16(1):15-21.Google Scholar
  7. Cameotra SS, Makkar RS: Synthesis of biosurfactants in extreme conditions. Appl Microbiol Biotechnol 1998, 50: 520-529. 10.1007/s002530051329View ArticleGoogle Scholar
  8. Chang CF, Su MS, Chen HY, Lo CF, Kou GH, Liao IC: “Effect of dietary β 1,3-glucan on resistance to white spot syndrome virus (WSSV) in postlarval and juvenile Penaeus monodon ”. Dis Aquat Organ 1999, 36: 163-168.View ArticleGoogle Scholar
  9. Cooper DG, Goldenberg BG: Surface-active agents from two Bacillus species. Appl Environ Microbiol 1987, 53: 224-229.Google Scholar
  10. De’ziel E, Le’pine F, Milot S, Villemur R: Mass spectrometry monitoring of rhamnolipids from a growing culture of Pseudomonas aeruginosa strain 57RP. Biochimica et BiophysicaActa 2000, 1485: 145-152. 10.1016/S1388-1981(00)00039-1View ArticleGoogle Scholar
  11. Fiechter A: . Trends Biotechnol 1992, 10: 208.View ArticleGoogle Scholar
  12. Freshney R: Culture of animal cells, a manual of basic technique 5th edn. New York: Wiley; 2007:365-368.Google Scholar
  13. George S, Jayachandran K: Analysis of rhamnolipid biosurfactants produced through submerged fermentation using orange fruit peelings as sole carbon source. Appl Biochem Biotechnol 2009, 158: 694-705. 10.1007/s12010-008-8337-6View ArticleGoogle Scholar
  14. Gutierrez T, Morris G, Green DH: Yield and physicochemical properties of EPS from Halomonas sp. strain TG39 identifies a role for protein and anionic residues (sulfate and phosphate) in emulsification of n-hexadecane. Biotechnol Bioeng 2009, 109(1):207-216.View ArticleGoogle Scholar
  15. Haba E, Espuny MJ, Busquets M, Manresa A: Screening and production of rhamnolipids by Pseudomonas aeruginosa 47T2 NCIB 40044 from waste frying oils. J Appl Microbiol 2000, 88(3):379-387. 10.1046/j.1365-2672.2000.00961.xView ArticleGoogle Scholar
  16. Holt JG, Krieg NR, Sheath PHA, Staley JT, Williams ST: Bergey’s Manual of determinative bacteriology. 9th edition. Baltimore: Williams and Wilkins; 1994.Google Scholar
  17. Isoda H, Shinmoto H, Matsumura M, Nakahara T: “Theneurite initiating effect of microbial extracellular glycolipids in PC12 cells”. Cytotechnology 1999, 31: 163-170.View ArticleGoogle Scholar
  18. Jain DK, Collins-Thompson DL, Lee H, Trevors JT: A drop-collapsing test for screening surfactant-producing microorganisms. J Microbiol Methods 1991, 13: 271-279. 10.1016/0167-7012(91)90064-WView ArticleGoogle Scholar
  19. Janek T, Łukaszewicz M, Rezanka T, Krasowska A: Isolation and characterization of two new lipopeptide biosurfactants produced by Pseudomonas fluorescens BD5 isolated from water from the arctic archipelago of Svalbard. Bioresour Technol 2010, 101: 6118-6123. 10.1016/j.biortech.2010.02.109View ArticleGoogle Scholar
  20. Joshi S, Bharucha C, Jha S, Yadav S, Nerurkar A, Desai AJ: “Biosurfactant production using molasses and whey under thermophilic conditions”. Bioresour Technol 2008, 99(1):195-199. 10.1016/j.biortech.2006.12.010View ArticleGoogle Scholar
  21. Karanth NGK, Deo PG, Veenanadig NK: Microbial production of biosurfactants and their importance. Curr Sci 1999, 77: 116-123.Google Scholar
  22. Kaye JZ, Baross JA: High incidence of halotolerant bacteria in Pacific hydrothermal-vent and pelagic environments. FEMS Microbiol Ecol 2000, 32: 249-260. 10.1111/j.1574-6941.2000.tb00718.xView ArticleGoogle Scholar
  23. Kemp W: Organic spectroscopy. Third edition. New York: Palgrave published; 1991:243-269.View ArticleGoogle Scholar
  24. Kosaric N: Biosurfactants. In Biotechnology vol. 6. Edited by: Rehm HJ, Reed G, Puhler A. Weinheim: VCH; 1996:659-717.Google Scholar
  25. Kumar M, Leon V, Materano ADS, Ilzins OA: Enhancement of oil degradation by co-culture of hydrocarbon degrading and biosurfactant producing bacteria. Pol J Microbiol 2006, 55: 139-146. 10.1099/jmm.0.46206-0View ArticleGoogle Scholar
  26. Martínez-Checa F, Toledo FL, Vílchez R, Quesada E, Calvo C: “Yield production, chemical composition and functional properties of emulsifier H28 synthesized by Halomonas eurihalina strain H-28 in media containing various hydrocarbons”. Appl Microbiol Biotechnol 2002, 58: 358-363. 10.1007/s00253-001-0903-6View ArticleGoogle Scholar
  27. Morita T, Konishi M, Fukuoka T, Imura T, Kitamoto D: Microbial conversion of glycerol into glycolipid biosurfactants, mannosylerythritol lipids, by a basidiomycete yeast, Pseudozyma antarctica JCM 10317. J Biosci Bioeng 2007, 104: 78-81. 10.1263/jbb.104.78View ArticleGoogle Scholar
  28. Namita R, Kumar S, Jaganmohan S, Murugan V: “DNA vaccines encoding viral envelope proteins confer protective immunity against WSSV in black tiger shrimp ”. Vaccine 2007, 25: 2778-2786. 10.1016/j.vaccine.2006.12.056View ArticleGoogle Scholar
  29. Nielsen T, Christophersen C, Anthoni U: Viscosinamide, a new cyclic depsipeptide with surfactant and antifungal properties produced by Pseudomonas fluorescens DR54. J Appl Microbiol 1999, 86: 80-90.View ArticleGoogle Scholar
  30. Peypoux F, Bonmatin J, Mand Wallach J: Recent trends in the biochemistry of surfactin. Appl Microbiol Biotechnol 1999, 51: 553-563. 10.1007/s002530051432View ArticleGoogle Scholar
  31. Ponder JW, Case DA: Force fields for protein simulations. Advances Prot Chemist 2003, 66: 27-85.View ArticleGoogle Scholar
  32. Post FJ, Collins NF: A preliminary investigation of the membrane lipid of Halobacterium halobium as a food additive. J Food Biochem 1982, 6: 25-38. 10.1111/j.1745-4514.1982.tb00294.xView ArticleGoogle Scholar
  33. Pruthi V, Cameotra SS: Production of a biosurfactant exhibiting excellent emulsification and surface active properties by Serratia marcescens . World J Microbiol Biotechnol 1997, 13: 133-135. 10.1007/BF02770821View ArticleGoogle Scholar
  34. Quesada E, Béjar V, Ferrer MR, Calvo C, Llamas I, Martínez-Checa F: “Moderately halophilic, exopolysaccharide - producing bacteria. In Halophilic microorganisms. Edited by: Ventosa A. Berlin: Heidelberg: Springer-Verlag; 2004:297-314.View ArticleGoogle Scholar
  35. Railkin AI: Behavioral and physiological reactions of hydroids and Bivalves to some antifouling substances. Zool Zhurnal 1994, 73(7-8):22-30.Google Scholar
  36. Romano I, Nicolaus B, Lama L, Manca MC, Gambacorta A: Characterization of a haloalkalophilic strictly aerobic bacterium, isolated from Pantelleria Island. Int J Syst Bacteriol 1997, 47: 601-602.View ArticleGoogle Scholar
  37. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual. Cold spring harbor laboratory press. NY: Cold Spring Harbor; 1989.Google Scholar
  38. Selvin J, Shanmughapriya S, Gandhimathi R, SeghalKiran G, RajeethaRavji T, Natarajaseenivasan T, Hema TA: “Optimization and production of novel antimicrobial agents from sponge associated marine actinomycetes Nocardiopsisdassonvillei MAD08”. Appl Microbiol Biotechnol 2009, 83: 435-445. 10.1007/s00253-009-1878-yView ArticleGoogle Scholar
  39. Siegmund L: “Biological amphiphiles (microbial biosurfactants)”. Current Opinion Colloid Interf Sci 2002, 7(1–2):12-20.Google Scholar
  40. Sneath PHA, Sokal RR: Numerical taxonomy. San Francisco: Freeman; 1973.Google Scholar
  41. Tamura K, Nei M, Kumar S: Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci 2004, 101: 11030-11035. 10.1073/pnas.0404206101View ArticleGoogle Scholar
  42. Tsuge K, Ano T, Shoba M: Isolation of a gene essential for biosynthesis of the lipopeptide antibiotics plipastatin B1 and surfactin in Bacillus subtilis YB8. Arch Microbiol 1996, 165: 243-251. 10.1007/s002030050322View ArticleGoogle Scholar
  43. Ventosa A, Nieto JJ, Oren A: Biology of moderately halophilic aerobic bacteria. Microbiol Mol Biol 1998, 62: 504-544.Google Scholar
  44. Vollenbroich D, Ozel M, Vater J, Kamp RM, Pauli G: Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis . Biologicals 1997, 25(3):289-297. 10.1006/biol.1997.0099View ArticleGoogle Scholar
  45. Warshel A, Sharma PK, Kato M, Parson WW: Modeling electrostatic effects in proteins. Biochimica et BiophysicaActa 2006, 1764: 1647-1676. 10.1016/j.bbapap.2006.08.007View ArticleGoogle Scholar
  46. Yeh MS, Wei YH, Chang JS: Bioreactor design for enhanced carrier-assisted surfactin production with Bacillus Subtilis . Process Biochem 2006, 41: 1799-1805. 10.1016/j.procbio.2006.03.027View ArticleGoogle Scholar
  47. Youssef NH, Duncan KE, Nagle DP, Savage KN, Knapp RM, McInerney MJJ: Comparison of methods to detect biosurfactant production by diverse microorganisms. J Microbiol Methods 2004, 56: 339-347. 10.1016/j.mimet.2003.11.001View ArticleGoogle Scholar
  48. Zhao X, Geltinger C, Kishikawa S: “Tretament of mouse melanoma cells with phorbol 12-myristate 13-acetate counteracts mannosylerythritol lipid-induced growth arrest and apoptosis”. Cytotechnology 2000, 33: 123-130. 10.1023/A:1008129616127View ArticleGoogle Scholar

Copyright

© Donio et al.; licensee Springer. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.